Is it time for a large trial to evaluate aspirin for obstetric venous thromboembolism prophylaxis?
- PMID: 39827893
- DOI: 10.1016/S2352-3026(24)00374-0
Is it time for a large trial to evaluate aspirin for obstetric venous thromboembolism prophylaxis?
Conflict of interest statement
AMF is supported by funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (1R01HD104943); however, this funding was not used to support this research. AMF has also served on an advisory board for Biogen and Sage.
Comment on
-
Low-dose aspirin versus placebo in postpartum venous thromboembolism: a multi-national, pilot, randomised, placebo-controlled trial.Lancet Haematol. 2025 Feb;12(2):e109-e119. doi: 10.1016/S2352-3026(24)00338-7. Epub 2025 Jan 16. Lancet Haematol. 2025. PMID: 39827892 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources
